CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.91
1.08%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.93
Open* 0.94
1-Year Change* -70.16%
Day's Range* 0.91 - 0.94
52 wk Range 0.61-3.48
Average Volume (10 days) 4.10M
Average Volume (3 months) 73.16M
Market Cap 413.61M
P/E Ratio -100.00K
Shares Outstanding 479.11M
Revenue 270.18M
EPS -0.73
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 9, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 5, 2023 0.93 0.00 0.00% 0.93 0.95 0.89
Dec 4, 2023 0.94 0.07 8.05% 0.87 0.97 0.87
Dec 1, 2023 0.87 0.02 2.35% 0.85 0.90 0.81
Nov 30, 2023 0.83 -0.05 -5.68% 0.88 0.89 0.83
Nov 29, 2023 0.87 0.00 0.00% 0.87 0.91 0.83
Nov 28, 2023 0.85 -0.03 -3.41% 0.88 0.88 0.83
Nov 27, 2023 0.88 -0.02 -2.22% 0.90 0.90 0.86
Nov 24, 2023 0.91 0.06 7.06% 0.85 0.91 0.85
Nov 22, 2023 0.85 0.00 0.00% 0.85 0.85 0.82
Nov 21, 2023 0.84 -0.02 -2.33% 0.86 0.86 0.81
Nov 20, 2023 0.88 0.05 6.02% 0.83 0.90 0.82
Nov 17, 2023 0.83 0.07 9.21% 0.76 0.84 0.75
Nov 16, 2023 0.74 -0.10 -11.90% 0.84 0.84 0.73
Nov 15, 2023 0.81 -0.03 -3.57% 0.84 0.86 0.81
Nov 14, 2023 0.81 0.00 0.00% 0.81 0.85 0.78
Nov 13, 2023 0.80 0.08 11.11% 0.72 0.84 0.71
Nov 10, 2023 0.71 0.01 1.43% 0.70 0.73 0.69
Nov 9, 2023 0.69 -0.17 -19.77% 0.86 0.86 0.69
Nov 8, 2023 0.88 -0.01 -1.12% 0.89 0.90 0.86
Nov 7, 2023 0.89 0.02 2.30% 0.87 0.89 0.84

23andMe Holding Co. Events

Time (UTC) Country Event
Friday, February 9, 2024

Time (UTC)

21:05

Country

US

Event

Q3 2024 23andMe Holding Co. Earnings Release
Q3 2024 23andMe Holding Co. Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 299.489 271.893 243.92 305.463 440.9
Revenue 299.489 271.893 243.92 305.463 440.9
Cost of Revenue, Total 164.993 138.948 126.914 168.031 248.01
Gross Profit 134.496 132.945 117.006 137.432 192.89
Total Operating Expense 623.5 526.046 429.116 563.91 629.683
Selling/General/Admin. Expenses, Total 235.911 197.721 142.346 169.911 241.141
Research & Development 222.596 189.377 159.856 181.276 140.532
Unusual Expense (Income) 0 0 44.692 0
Operating Income -324.011 -254.153 -185.196 -258.447 -188.783
Interest Income (Expense), Net Non-Operating 9.676 0.277 1.577 7.584 5.25
Net Income Before Taxes -314.428 -220.97 -183.619 -250.863 -183.533
Net Income After Taxes -311.656 -217.49 -183.619 -250.863 -183.533
Net Income Before Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
Net Income -311.656 -217.49 -183.619 -250.863 -183.533
Income Available to Common Excl. Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
Income Available to Common Incl. Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
Diluted Net Income -311.656 -217.49 -183.619 -250.863 -183.533
Diluted Weighted Average Shares 451.504 361.528 43.4498 38.4538 34.4825
Diluted EPS Excluding Extraordinary Items -0.69026 -0.60159 -4.226 -6.52376 -5.3225
Diluted Normalized EPS -0.67591 -0.60159 -4.21449 -5.34333 -5.3225
Other, Net -0.093 32.906
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 60.864 92.377 66.94 75.659 64.513
Revenue 60.864 92.377 66.94 75.659 64.513
Cost of Revenue, Total 30.184 52.395 36.189 37.386 39.023
Gross Profit 30.68 39.982 30.751 38.273 25.49
Total Operating Expense 170.128 161.651 164.04 143.7 154.109
Selling/General/Admin. Expenses, Total 73.398 48.537 70.581 53.716 63.077
Research & Development 62.329 60.719 57.27 52.598 52.009
Unusual Expense (Income) 4.217
Operating Income -109.264 -69.274 -97.1 -68.041 -89.596
Interest Income (Expense), Net Non-Operating 4.307 4.369 3.671 1.392 0.245
Other, Net 0.333 0.174 0.855 -0.687 -0.435
Net Income Before Taxes -104.624 -64.731 -92.574 -67.336 -89.786
Net Income After Taxes -104.624 -64.098 -91.961 -66.065 -89.532
Net Income Before Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
Net Income -104.624 -64.098 -91.961 -66.065 -89.532
Income Available to Common Excl. Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
Income Available to Common Incl. Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
Diluted Net Income -104.624 -64.098 -91.961 -66.065 -89.532
Diluted Weighted Average Shares 462.254 456.168 453.407 449.9 446.505
Diluted EPS Excluding Extraordinary Items -0.22633 -0.14051 -0.20282 -0.14684 -0.20052
Diluted Normalized EPS -0.21668 -0.14051 -0.18853 -0.14655 -0.20023
Dividends per Share - Common Stock Primary Issue 0 0 0 0
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 424.992 601.789 313.575 252.521
Cash and Short Term Investments 386.849 553.182 282.489 207.942
Cash 386.849 553.182 282.489 207.942
Total Receivables, Net 1.897 3.38 2.481 6.392
Accounts Receivable - Trade, Net 1.897 3.38 2.481 6.392
Total Inventory 10.247 10.789 6.239 14.122
Prepaid Expenses 19.224 25.139 15.485 13.088
Other Current Assets, Total 6.775 9.299 6.881 10.977
Total Assets 942.598 1152.07 452.098 404.63
Property/Plant/Equipment, Total - Net 94.686 105.428 124.006 138.49
Property/Plant/Equipment, Total - Gross 170.002 168.052 174.334 172.773
Accumulated Depreciation, Total -75.316 -62.624 -50.328 -34.283
Intangibles, Net 61.181 83.54 6.889 5.417
Other Long Term Assets, Total 9.995 9.567 7.628 8.202
Total Current Liabilities 149.416 153.241 121.619 139.448
Accounts Payable 12.924 37.93 12.271 13.085
Accrued Expenses 72.615 50.336 37.758 41.616
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 63.877 64.975 71.59 84.747
Total Liabilities 228.659 236.412 210.366 270.43
Total Long Term Debt 0 0 0 0
Other Liabilities, Total 79.243 83.171 88.747 130.982
Total Equity 713.939 915.656 241.732 134.2
Redeemable Preferred Stock 0 837.351 755.083
Common Stock 0.046 0.045 0 0
Additional Paid-In Capital 2220.9 2110.16 381.619 172.736
Retained Earnings (Accumulated Deficit) -1506.38 -1194.73 -977.238 -793.619
Total Liabilities & Shareholders’ Equity 942.598 1152.07 452.098 404.63
Total Common Shares Outstanding 461.2 448.812 54.2921 44.3183
Total Preferred Shares Outstanding 91.1984 86.4433
Goodwill, Net 351.744 351.744
Other Equity, Total -0.62 0.179
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 297.995 360.276 424.992 508.671 506.205
Cash and Short Term Investments 256.386 314.351 386.849 432.801 410.891
Cash 256.386 314.351 386.849 432.801 410.891
Total Receivables, Net 1.501 4.124 1.897 26.808 52.883
Accounts Receivable - Trade, Net 1.501 4.124 1.897 26.808 52.883
Total Inventory 14.979 11.815 10.247 11.96 13.806
Prepaid Expenses 17.948 21.286 19.224 21.367 20.24
Other Current Assets, Total 7.181 8.7 6.775 15.735 8.385
Total Assets 801.23 871.199 942.598 1024.65 1040.73
Property/Plant/Equipment, Total - Net 85.354 90.033 94.686 90.778 95.945
Property/Plant/Equipment, Total - Gross 166.116 167.794 170.002 162.96 165.783
Accumulated Depreciation, Total -80.762 -77.761 -75.316 -72.182 -69.838
Intangibles, Net 56.806 59.56 61.181 63.185 76.435
Other Long Term Assets, Total 9.331 9.586 9.995 10.276 10.403
Total Current Liabilities 101.601 118.909 149.416 200.113 144.906
Accounts Payable 8.546 12.748 12.924 13.984 10.549
Accrued Expenses 51.899 56.695 72.615 75.624 51.233
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 41.156 49.466 63.877 110.505 83.124
Total Liabilities 175.979 195.709 228.659 273.662 221.412
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 74.378 76.8 79.243 73.549 76.506
Total Equity 625.251 675.49 713.939 750.992 819.32
Redeemable Preferred Stock
Common Stock 0.048 0.047 0.046 0.045 0.045
Additional Paid-In Capital 2311.48 2287.41 2220.9 2193.54 2167.97
Retained Earnings (Accumulated Deficit) -1686.28 -1611.01 -1506.38 -1442.29 -1350.32
Total Liabilities & Shareholders’ Equity 801.23 871.199 942.598 1024.65 1040.73
Total Common Shares Outstanding 478.831 472.096 461.2 457.161 455.453
Goodwill, Net 351.744 351.744 351.744 351.744 351.744
Other Equity, Total 0 -0.954 -0.62 -0.311 1.632
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line -311.656 -217.49 -183.619 -250.863 -183.533
Cash From Operating Activities -165.39 -166.828 -74.252 -185.766 -98.117
Cash From Operating Activities 32.071 23.699 18.078 22.249 9.901
Amortization 4.427 2.449 2.168 1.04 0
Non-Cash Items 125.725 16.23 71.396 42.724 52.952
Changes in Working Capital -15.957 8.284 17.725 -0.916 22.563
Cash From Investing Activities -11.305 -108.137 -6.536 -72.823 -27.84
Capital Expenditures -11.31 -13.973 -7.374 -73.588 -27.84
Other Investing Cash Flow Items, Total 0.005 -94.164 0.838 0.765 0
Cash From Financing Activities 9.777 546.004 155.335 8.83 344.448
Financing Cash Flow Items -0.89 -30.642 -3.316 0 -0.394
Issuance (Retirement) of Stock, Net 10.667 576.646 158.651 8.83 344.842
Net Change in Cash -166.533 270.893 74.547 -249.759 218.491
Foreign Exchange Effects 0.385 -0.146
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -311.656 -247.558 -155.597 -89.532 -217.49
Cash From Operating Activities -165.39 -120.429 -145.974 -73.04 -166.828
Cash From Operating Activities 32.071 24.918 16.747 8.36 23.699
Amortization 4.427 3.214 2.078 1.052 2.449
Non-Cash Items 125.725 149.89 78.418 17.355 16.23
Changes in Working Capital -15.957 -50.893 -87.62 -10.275 8.284
Cash From Investing Activities -11.305 -8.017 -4.951 -2.9 -108.137
Capital Expenditures -11.31 -8.017 -4.953 -2.9 -13.973
Other Investing Cash Flow Items, Total 0.005 0 0.002 -94.164
Cash From Financing Activities 9.777 7.171 7.182 1.533 546.004
Financing Cash Flow Items -0.89 0 0 0 -30.642
Issuance (Retirement) of Stock, Net 10.667 7.171 7.182 1.533 576.646
Net Change in Cash -166.533 -120.581 -142.291 -73.784 270.893
Foreign Exchange Effects 0.385 0.694 1.452 0.623 -0.146
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.9385 27256007 -306490 2023-06-30 LOW
Newview Capital Management, LLC. Venture Capital 6.3804 19455681 0 2023-06-30 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.6897 17349340 717618 2023-06-30 LOW
Euclidean Capital, L.L.C. Investment Advisor 3.3592 10243122 0 2023-06-30 MED
Fidelity Management & Research Company LLC Investment Advisor 2.2996 7012254 187220 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.0278 6183243 576924 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8421 5617120 254321 2023-06-30 LOW
Sapphire Ventures, LLC Investment Advisor/Hedge Fund 1.7354 5291824 0 2023-06-30 MED
Wojcicki (Anne) Individual Investor 1.0762 3281613 -312356 2023-07-10
Renaissance Technologies LLC Hedge Fund 0.8227 2508729 977329 2023-06-30 HIGH
Alibaba Group Holding Ltd. Corporation 0.6947 2118444 0 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.6907 2106225 21160 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.6692 2040726 -83543 2023-06-30 LOW
Voya Investment Management LLC Investment Advisor/Hedge Fund 0.5418 1652033 726742 2023-06-30 LOW
ACATIS Investment Kapitalverwaltungsgesellschaft GmbH Investment Advisor 0.4919 1500000 0 2023-06-30 LOW
Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 0.4368 1332011 -813862 2023-06-30 LOW
Lovell (Evan M) Individual Investor 0.4029 1228544 1217077 2022-08-11
Two Sigma Investments, LP Hedge Fund 0.3974 1211636 -995506 2023-06-30 HIGH
Hibbs (Kathy L) Individual Investor 0.3754 1144697 0 2023-10-19 HIGH
Selsavage (Joseph Anthony) Individual Investor 0.3657 1115162 1025992 2023-09-15 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

23andMe Holding Co. Company profile

23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers'' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. The company was founded in 2006 and is headquartered in Sunnyvale, California.
Industry: Medical & Diagnostic Laboratories

349 Oyster Point Boulevard
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

XRP/USD

0.64 Price
+1.460% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

15,856.20 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

44,119.40 Price
+0.200% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,030.07 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading